1. EachPod
EachPod

S3, E1: How Xaira Therapeutics went from incubation to a billion dollar launch - with Vik Bajaj, CEO Foresite Labs

Author
Surani Fernando
Published
Wed 02 Jul 2025
Episode Link
None

In this episode, we go inside the creation of Xaira Therapeutics — the biotech startup that raised over a billion dollars at launch without a product or clinical data.

Speaking with Vik Bajaj, CEO and co-founder of Foresite Labs (and one of the people behind Xaira’s creation), Surani explores how Xaira’s approach could redefine biotech company building, why it’s different from typical AI hype, and what makes it such a bold bet.

We follow Vik’s journey from academia to Google to Grail, and then into biotech investing with Foresite Labs, uncovering how a unique incubator model led to Xaira’s launch. From the big idea to the billion-dollar financing, we unpack what’s really happening behind the headlines.

Timestamps:


00:00 – Introduction: Why Xaira’s billion-dollar launch matters


01:00 – Vik Bajaj’s journey from academia to Google and Grail


04:00 – Moving from big tech to biotech: lessons and perspective


06:00 – Founding Foresite Labs and its unique model for biotech incubation


08:00 – Why data generation is key in biotech AI


09:00 – Foresite’s approach: building data, tools, and teams from scratch


11:00 – The origins of Xaira: ideation, science, and assembling the team


13:00 – Bringing in David Baker’s advanced protein design technology


16:00 – Early team building and leveraging Grail and Illumina networks


17:00 – Xaira’s $1B+ fundraising: why it happened and what it means


20:00 – Why Xaira needed so much capital up front


21:30 – What separates Xaira from other AI drug discovery companies


22:30 – The ambition to build a foundation model of the cell (GPT for biology)


23:00 – De novo design: creating antibodies from scratch


24:30 – Building products and platforms in parallel — not sequentially


26:00 – Where Xaira is today and Foresite’s ongoing role


27:00 – Vik’s vision for success: timelines and goals for Xaira


28:00 – Reflections: Can Xaira’s model really change how biotech is built?


29:00 – Outro: What to watch next, and how to support the podcast

For any comments, questions, feedback or suggestions you can connect directly with ⁠⁠Surani Fernando⁠⁠ on LinkedIn or email: [email protected]

Title music composed by: Yrii Semchyshyn (Coma Media)

Share to: